Survival analysis in the same cohort of 101 neuroblastoma tumors showed association of decreased mRNA expression levels of both RGS5 and RNF11 with poor survival (p = 4.8E-2; p = 6.4E-4), which is in line with the observed association of both genes with MYCN expression. The gene discussed is RGS5; the disease is neuroblastoma.